Unless Congress closes a loophole in the orphan drug law, new products containing the opioid addiction treatment buprenorphine could be blocked from the market until 2024.

Many asylum cases tied to trauma could be strengthened by medical and psychological evaluations, lawyers say. But not enough doctors provide or are trained to do them.